Skip to main content
Premium Trial:

Request an Annual Quote

Nanophere's Product Sales Offset Lost Contracts, Lower Grant Revenue in Q2

NEW YORK (GenomeWeb News) – Nanosphere reported after the close of the market on Tuesday that its second-quarter revenues declined around 2 percent year over year, as a 60 percent increase in product sales largely made up for its loss of grant and contract revenue.

The Northbrook, Ill.-based molecular diagnostics firm brought in total revenues of $509,000 for the three-month period ended June 30, down from $517,000 for Q2 2010.

All of its revenues came from product sales, compared with $319,000 in product sales for the year-ago period. Nanosphere received no grant or contract revenues in the quarter compared to $198,000 from grants and contracts in Q2 2010.

The firm's net loss for the quarter was $8.4 million, or $.23 per share, compared to a net loss of $13.8 million, or $.50 per share, for the second quarter of 2011. That loss beat analysts' expectations of a loss of $.26 per share.

Nanosphere said the drop in its net loss was due largely to litigation costs and a legal contingency reserve it incurred in the year-ago period related to a patent dispute with Eppendorf.

Nanosphere's R&D spending was flat year over year at $4.6 million, while its SG&A spending was cut 57 percent to $3.9 million from $9.1 million.

"We are focused on menu expansion, building a loyal and engaged customer base and growing our market presence," Nanosphere President and CEO William Moffitt said in a statement.

Nanosphere finished the quarter with cash and cash equivalents of $54.5 million.

The company closed a public offering in May that raised net proceeds of $32.2 million.

In early morning trading on Wednesday on Nasdaq, shares of Nanosphere were down almost 3 percent to $1.43.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.